Bulletin
Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Teva Pharmaceutical Industries Ltd. ADR

After Hours

TEVA
/zigman2/quotes/205657894/composite

$

11.16

Change

-0.04 -0.36%

Volume

Volume 30,392

Aug 15, 2022, 7:24 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205657894/composite

Today's close

$ 11.21

$ 11.20

Change

-0.01 -0.09%

Day low

Day high

$10.92

$11.28

Open
Open: 10.97

52 week low

52 week high

$6.78

$11.34

Open

Market cap

$12.49B

Average volume

14.56M

P/E ratio

N/A

Rev. per Employee

$410,182

EPS

-0.95

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  1. Teva Pharmaceutical upgraded to buy from neutral at BofA Securities

    9:44 a.m. Aug. 5, 2022

    - Tomi Kilgore

  3. $4.4 Billion Opioid Settlement Gives Teva Stock a Boost

    3:32 a.m. July 28, 2022

    - Barron's Online

  4. Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement

    6:14 a.m. July 27, 2022

    - Barron's Online

  8. Teva to pay $75 mln over 15 years to settle opioid claims from W. Va., plus pay $8 mln in legal fees

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  9. Teva settlement with W. Va. also includes $27 mln worth of generic Narcan over 10 years

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  10. W. Va. says Teva opioid agreement consistent with previously announced settlements

    9:46 a.m. May 25, 2022

    - Steve Gelsi

  11. Teva Pharmaceutical upgraded to neutral from underperform at BofA Securities

    9:36 a.m. May 17, 2022

    - Tomi Kilgore

  12. Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion

    10:06 a.m. May 10, 2022

    - Barron's Online

  13. Teva CEO Sees a Final Opioid Settlement Coming This Year

    4:58 p.m. May 3, 2022

    - Barron's Online

  16. Teva now sees full-year revenue of $15.4 bln to $16.0 bln vs. prior guidance of $15.6 bln to $16.2 bln

    7:19 a.m. May 3, 2022

    - Ciara Linnane

  17. Teva now sees full-year EPS of $2.40 to $2.60, unchanged vs. prior guidance

    7:20 a.m. May 3, 2022

    - Ciara Linnane

  18. Teva lowers full-year revenue guidance

    7:19 a.m. May 3, 2022

    - Ciara Linnane

  19. Teva Q1 adj. EPS 55 cents; FactSet consensus 53 cents

    7:17 a.m. May 3, 2022

    - Ciara Linnane

  20. Teva Q1 revenue $3.661 bln, down 8%; FactSet consensus $3.598 bln

    7:18 a.m. May 3, 2022

    - Ciara Linnane

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision

    10:05 a.m. Today

    - Zacks.com

  2. Walgreens Helped Fuel San Francisco Opioid Epidemic, Judge Rules

    4:57 p.m. Aug. 10, 2022

    - Jennifer Calfas

  3. Walgreens Helped Fuel San Francisco Opioid Epidemic, Judge Rules

    4:57 p.m. Aug. 10, 2022

    - Jennifer Calfas

  4. Drugmaker Endo Says Bankruptcy Likely Imminent

    8:19 p.m. Aug. 9, 2022

    - Alexander Gladstone

  7. Miller Opportunity Trust 2Q 2022 Quarterly Investment Review

    10:21 a.m. Aug. 6, 2022

    - Seeking Alpha

  8. Why Teva Stock Trounced the Market on Friday

    5:04 p.m. Aug. 5, 2022

    - Motley Fool

  9. Is This Rare Berkshire Hathaway Miscue Finally a Buy?

    8:25 a.m. Aug. 3, 2022

    - Motley Fool

  11. Viatris: A Spinoff To Own

    10:40 p.m. Aug. 1, 2022

    - Seeking Alpha

  14. Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30%

    1:10 p.m. July 28, 2022

    - Seeking Alpha

  15. Teva Tries to Put an End to the Opioid Wars

    7:03 a.m. July 28, 2022

    - David Wainer

  18. 10-Q: TEVA PHARMACEUTICAL INDUSTRIES LTD

    4:09 p.m. July 27, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  20. Teva adds a record 22% as 2Q update addresses opioid uncertainty

    12:36 p.m. July 27, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. Teva Pharmaceutical (TEVA) Trading Report

    4:21 a.m. Aug. 12, 2022

    - Stock Traders Daily

  2. Thursday's ETF with Unusual Volume: HEFA

    12:42 p.m. Aug. 11, 2022

    - MarketNewsVideo.com

  3. How To Trade Invalid Iqfeed Symbol TEVA

    11:02 a.m. Aug. 2, 2022

    - Stock Traders Daily

  5. Teva Reports Second Quarter 2022 Financial Results

    4:55 p.m. July 26, 2022

    - BusinessWire - BZX

  6. Certara Appoints Rosemary Crane as New Independent Board Member

    8:00 a.m. July 25, 2022

    - GlobeNewswire

  7. Teva Pharmaceutical (TEVA) Trading Report

    7:56 p.m. July 23, 2022

    - Stock Traders Daily

  12. Trend Tracker for Teva Pharmaceutical TEVA

    10:52 a.m. July 10, 2022

    - Stock Traders Daily

  14. Teva Pharmaceutical (TEVA) Trading Report

    5:27 p.m. June 30, 2022

    - Stock Traders Daily

  17. Teva Pharmaceutical TEVA Proactive Strategies

    10:36 p.m. June 20, 2022

    - Stock Traders Daily

  18. Migraine Treatment Drugs Market Size, Share | Global Report [2028]

    12:58 a.m. June 16, 2022

    - AmericaNewsHour

  19. Learn to Evaluate Teva Pharmaceutical (TEVA) using the Charts

    11:12 p.m. June 9, 2022

    - Stock Traders Daily

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.